Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 53, 2023 - Issue 21
115
Views
0
CrossRef citations to date
0
Altmetric
Articles

Development of a new synthetic route of the key intermediate of riociguat

, , , &
Pages 1844-1853 | Received 30 Mar 2023, Published online: 29 Aug 2023
 

Abstract

Herein, we describe a new synthetic route to prepare 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile (9), a key intermediate of riociguat (1). In this new route, 9 was obtained from commercially available methyl 2-chloronicotinate (28) as the staring material in four steps with an overall yield of 55%. The hydrazinolysis and intramolecular substitution were completed in one step to obtain 1H-pyrazolo[3,4-b]pyridin-3-ol (30). Regioselective N1-benzylation of 30 afforded 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-ol (31), whose structure was confirmed by 1H NMR, 13C NMR, MS and single-crystal X-ray crystallography. Pd-catalyzed cyanation of 1-(2-fluorobenzyl)-3-bromo-1H-pyrazolo[3,4-b]pyridine (32) was applied to prepare key intermediate 9. Compound 32 in our approach has not been previously reported in the literature. The related impurities and process parameters were studied. The new synthetic route provides an alternative method for the preparation of riociguat.

Graphical Abstract

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.